Literature DB >> 7263312

Study of the HLA system in Burkitt's lymphoma.

E H Jones, R J Biggar, F K Nkrumah, S D Lawler.   

Abstract

Seventy-eight patients with Burkitt's lymphoma and seventy controls from Ghana were typed for HLA-A, B, C and DR antigens, to determine whether there is an association between the HLA system and Burkitt's lymphoma. Increased relative risk was observed in Burkitt's lymphoma patients with DR7, HLA-A1 and B12(BW44).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7263312     DOI: 10.1016/0198-8859(80)90015-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  The role of human leucocyte antigen genes in the development of malignant disease.

Authors:  W M Howell; D B Jones
Journal:  Clin Mol Pathol       Date:  1995-12

2.  Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R D Schrier; C A Wiley; C Spina; J A McCutchan; I Grant
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  The HLA system: structure and function.

Authors:  W F Bodmer
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

4.  Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group.

Authors:  R D Schrier; W R Freeman; C A Wiley; J A McCutchan
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda.

Authors:  Samuel Kirimunda; Murielle Verboom; Isaac Otim; Mark Ssennono; Ismail D Legason; Hadijah Nabalende; Martin D Ogwang; Patrick Kerchan; Tobias Kinyera; Ivan Mwebaza; Moses Joloba; Leona W Ayers; Steven J Reynolds; Kishor Bhatia; Olusegun O Onabajo; Michael Hallensleben; Robert J Biggar; Ludmila Prokunina-Olsson; James J Goedert; Rainer Blasczyk; Sam M Mbulaiteye
Journal:  Br J Haematol       Date:  2020-02-18       Impact factor: 8.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.